Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: Possible role of E2F-mediated upregulation of PACE4 in tumor progression

Gene

Volumn 402, Issue 1-2, 2007, Pages 103-110

  Yuasa, Keizo ^a   Suzue, Kaori ^a   Nagahama, Masami ^a   Matsuda, Yoshiko ^a   Tsuji, Akihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Invasion; MMP; Processing protease; Transcription; Tumorigenesis

Indexed keywords

FURIN; PROPROTEIN CONVERTASE PACE4; PROTEIN PC6; SERINE PROTEINASE; SUBTILISIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER INVASION; CONTROLLED STUDY; DNA FLANKING REGION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION;

BINDING SITES; CELL LINE, TUMOR; DISEASE PROGRESSION; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 34548670497     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.07.028     Document Type: Article

References (34)

1. Akamatsu T., et al. Developmental expression of a novel Kexin family protease, PACE4E, in the rat olfactory system. Histochem. Cell Biol. 108 (1997) 95-103
2. Akamatsu T., et al. Highly regulated expression of subtilisin-like proprotein convertase PACE4 (SPC4) during dentinogenesis. Biochem. Biophys. Res. Commun. 272 (2000) 410-415
3. Banerjee D., et al. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res. 60 (2000) 2365-2367
4. Bassi D.E., Mahloogi H., and Klein-Szanto A.J. The proprotein convertases furin and PACE4 play a significant role in tumor progression. Mol. Carcinog. 28 (2000) 63-69
5. Bassi D.E., Fu J., Lopez de Cicco R., and Klein-Szanto A.J. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 44 (2005) 151-161
6. Cheng M., Watson P.H., Paterson J.A., Seidah N., Chrétien M., and Shiu R.P. Pro-protein convertase gene expression in human breast cancer. Int. J. Cancer 71 (1997) 966-971
7. Christofori G., Naik P., and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 (1994) 414-418
8. Classon M., and Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2 (2002) 910-917
9. Claudio P.P., et al. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res. 61 (2001) 462-468
10. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
11. Cress W.D., Johnson D.G., and Nevins J.R. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13 (1993) 6314-6325
12. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
13. Duguay S.J., Jin Y., Stein J., Duguay A.N., Gardner P., and Steiner D.F. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J. Biol. Chem. 273 (1998) 18443-18451
14. Foulstone E., et al. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J. Pathol. 205 (2005) 145-153
15. Hubbard F.C., et al. Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability. Cancer Res. 57 (1997) 5226-5231
16. Johansson N., Ahonen M., and Kähäri V.M. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 57 (2000) 5-15
17. Koide S., Yoshida I., Tsuji A., and Matsuda Y. The expression of proprotein convertase PACE4 is highly regulated by Hash-2 in placenta: possible role of placenta-specific basic helix-loop-helix transcription factor, human achaete-scute homologue-2. J. Biochem. 134 (2003) 433-440
18. Li J., et al. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene 13 (1996) 2379-2386
19. Maddison L.A., Sutherland B.W., Barrios R.J., and Greenberg N.M. Conditional deletion of Rb caused early stage prostate cancer. Cancer Res. 64 (2004) 6018-6025
20. Mahloogi H., Bassi D.E., and Klein-Szanto A.J. Malignant conversion of nontumorigenic murine skin keratinocytes overexpressing PACE4. Carcinogenesis 23 (2002) 565-572
21. Maquoi E., Noel A., Frankenne F., Angliker H., Murphy G., and Foidart J.M. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett. 424 (1998) 262-266
22. Rasheed S., Nelson-Rees W.A., Toth E.M., Arnstein P., and Gardner M.B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33 (1974) 1027-1033
23. Rotheneder H., Geymayer S., and Haidweger E. Transcription factors of the Sp1 family: Interaction with E2F and regulation of the murine thymidine kinase promoter. J. Mol. Biol. 293 (1999) 1005-1015
24. Siegfried G., et al. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J. Clin. Invest. 111 (2003) 1723-1732
25. Sato H., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
26. Stanelle J., Stiewe T., Theseling C.C., Peter M., and Pützer B.M. Gene expression changes in response to E2F1 activation. Nucleic Acids Res. 30 (2002) 1859-1867
27. Steiner D.F. The proprotein convertases. Curr. Opin. Chem. Biol. 2 (1998) 31-39
28. Stevens C., and La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412 (2003) 157-169
29. Suzuki T., Yasui W., Yokozaki H., Naka K., Ishikawa T., and Tahara E. Expression of the E2F family in human gastrointestinal carcinomas. Int. J. Cancer 81 (1999) 535-538
30. Tsuji A., et al. Genomic organization and alternative splicing of human PACE4 (SPC4), kexin-like processing endoprotease. J. Biochem. 122 (1997) 438-452
31. Tsuji A., et al. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim. Biophys. Acta 1645 (2003) 95-104
32. Yana I., and Weiss S.J. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell 11 (2000) 2387-2401
33. Yang Y.W., Romanus J.A., Liu T.Y., Nissley S.P., and Rechler M.M. Biosynthesis of rat insulin-like growth factor II. I. Immunochemical demonstration of a approximately 20-kilodalton biosynthetic precursor of rat insulin-like growth factor II in metabolically labeled BRL-3A rat liver cells. J. Biol. Chem. 260 (1985) 2570-2577
34. Zhang S.Y., Liu S.C., Johnson D.G., and Klein-Szanto A.J. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res. 60 (2000) 5972-5976